TP53 and neoplasm: TP53 shows significantly reduced expression (p = 1.0 × 10−3; FDR = 8.7 × 10−2; Wilcoxon rank-sum test) across six tumors with TP53 promoter mutations from six different tumor types (Fig. 3a; Supplementary Fig. 10).